Sancti Spiritus, Cuba, Aug 17 (Prensa Latina) The phase III clinical trial to evaluate the efficacy and safety of the neuroprotective drug NeuralCIM in patients with mild or moderate Alzheimer's amnestic variant is progressing positively today in this central province of Cuba.
Beijing, Apr 2 (Prensa Latina) Cuban Deputy Prime Minister Jorge Luis Perdomo praised the work carried out by Biotech Pharma (BPL), a joint venture with China in biotechnology, and expressed confidence that they will achieve greater results with their future projections.
Sancti Spiritus, Cuba, Mar 6 (Prensa Latina) The 3rd phase of clinical trials to evaluate the efficacy and safety of the NeuralCIM neuroprotective drug in patients with mild or moderate Alzheimer's amnesic variant is being carried out in this central Cuban province, medical specialists reported on Monday.
Havana, Feb 26 (Prensa Latina) President Miguel Diaz-Canel on Sunday described the beginning of a clinical trial on the drug NeuralCIM to treat mild or moderate Alzheimer's disease as a new challenge and contribution from Cuba's science.
Havana, Jan 24 (Prensa Latina) Cuban Deputy Prime Minister Jorge Luis Perdomo met on Tuesday with US scientists from the Roswell Park Cancer Institute (RPCI), who are visiting Havana to expand collaboration with local institutions.